Lisata Therapeutics (0HS8) Financial Statements
Lisata Therapeutics Financial Overview
Lisata Therapeutics's market cap is currently $11.02M. The company's EPS TTM is $-1.64; its P/E ratio is -0.62; Lisata Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 170.00K | $ 1.00M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 24.00K | $ 1.00M | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -18.21M | $ -22.41M | $ -25.71M | $ -57.60M | $ -29.05M |
| EBITDA | $ -17.40M | $ -20.61M | $ -22.98M | $ -56.63M | $ -28.92M |
| Net Income | $ -16.59M | $ -19.98M | $ -20.84M | $ -54.23M | $ -27.47M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 15.96M | $ 31.25M | $ 50.53M | $ 69.23M | $ 94.97M |
| Total Assets | $ 17.74M | $ 35.00M | $ 54.69M | $ 73.03M | $ 97.01M |
| Total Debt | $ 0.00 | $ 137.00K | $ 168.00K | $ 485.00K | $ 714.00K |
| Net Debt | $ -15.96M | $ -16.07M | $ -22.43M | $ -31.67M | $ -23.93M |
| Total Liabilities | $ 3.14M | $ 5.68M | $ 6.80M | $ 6.71M | $ 5.01M |
| Stockholders' Equity | $ 14.86M | $ 29.57M | $ 48.15M | $ 66.58M | $ 92.25M |
| Cash Flow | |||||
| Free Cash Flow | $ -15.98M | $ -19.36M | $ -20.03M | $ -21.45M | $ -22.30M |
| Operating Cash Flow | $ -15.95M | $ -19.36M | $ -20.03M | $ -21.17M | $ -22.25M |
| Investing Cash Flow | $ 15.09M | $ 13.23M | $ 10.10M | $ 28.91M | $ -54.90M |
| Financing Cash Flow | $ 599.00K | $ -206.00K | $ 385.00K | $ -224.00K | $ 85.28M |
Currency in USD
